Antihistamines as an adjunct to topical nasal steroids for intermittent and persistent allergic rhinitis in children

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Nasser, Mona ^a   Aljufairi, H ^b   McKerrow, W S ^b   Fedorowicz, Z ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ASTEMIZOLE; BECLOMETASONE; BETAMETHASONE; BROMPHENIRAMINE; BUCLIZINE; BUDESONIDE; CARBINOXAMINE; CETIRIZINE; CLEMASTINE; CORTICOSTEROID; CYPROHEPTADINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE; DIMENHYDRINATE; DIMETINDENE; EBASTINE; FEXOFENADINE; FLUTICASONE; GLUCOCORTICOID; HYDROXYZINE; KETOTIFEN; LORATADINE; MECLOZINE; PLACEBO; STEROID; TRIAMCINOLONE; UNINDEXED DRUG;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HAY FEVER; HUMAN; OUTCOME ASSESSMENT; PERENNIAL RHINITIS; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949192007     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006989     Document Type: Review

References (23)

1. AHRQ 2002 Management of Allergic and Nonallergic Rhinitis. Summary, Evidence Report/Technology Assessment. Agency for Healthcare Research and Quality, U.S. Department of Health and Human Sciences 2002, issue 54.
2. Al Sayyad 2007 Al Sayyad J, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database of Systematic Reviews 2007, Issue 1.
3. ARIA 2001 Bousquet J, van Cauwenberge P, Khaltaev N. Allergic Rhinitis and its Impact on Asthma (ARIA). Journal of Allergy and Clinical Immunology 2001;108(5 suppl):S147-S336.
4. BNF 2004 Mehta D (ed). British National Formulary. 8th Edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain, 2004.
5. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
6. Fireman 2000 Fireman P. Therapeutic approaches to allergic rhinitis: Treating the child. Journal of Allergy and Clinical Immunology 2000;105:616-21.
7. Gazis 1999 Gazis AG, Homer JJ, Henson DB, Jones NS. The effect of six weeks of topical betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis. Clinical Otolaryngology 1999;24(6):495-8.
8. Gelfand 2005 Gelfand EW. Pediatric allergic rhinitis: factors affecting treatment choice. Ear, Nose and Throat Journal 2005;84(3):163-8.
9. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
10. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd 2005.
11. Johansson 1997 Johansson SG. The discovery of IgE and its importance for allergologists. Nordisk medicin 1997;112(4):115-8.
12. Long 2002 Long A, McFadden C, DeVine D, Chew P, Kupelnick B, Lau J. Management of allergic and nonallergic rhinitis. Agency for Healthcare Research and Quality, Rockville, MD, USA 2002; Vol. 198.
13. Marinho 2006 Marinho S, Simpson A, Custovic A. Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work?. Primary care respiratory journal : journal of the General Practice Airways Group 2006;15(3):152-8.
14. Rak 1994 Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, et al.Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasalmucosa after allergen challenge. Clinical and Experimental Allergy 1994;24:930-9.
15. RevMan 2005 The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2005.
16. Rossi 2004 Rossi S (Ed.). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd, 2004.
17. Sheikh 2007 Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1.
18. Skoner 2000 Skoner D, Rachelefsky G, Meltzer E, et al.Detection of growth supression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105(2):E23.
19. Spector 1999 Spector SL. Pathophysiology and pharmacotherapy of allergic rhinitis. Journal of Allergy and Clinical Immunology 1999;103(3 pt 2):S377.
20. Spector 2003 Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, Dykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, Tilles SADykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, Tilles SA Dykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, Tilles SA Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, Dykewicz MS, Fineman SM, Lee RE, Li JT, Portnoy JM, Schuller DE, Lang D, Tilles SA. Symptom severity assessment of allergic rhinitis: part 1. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2003;91(2):105-14.
21. van Cauwenberge 2000 van Cauwenberge P, Bachert C, Passalaqua G, Bousquet J, Canonica GW, Durham SR, et al.Consensus statement on the treatment of allergy rhinitis. Allergy 2000;55(2):116-34.
22. Weiner 1998 Weiner J, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-9.
23. Yanez 2002 Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Annals of Allergy, Asthma and Immunology 2002;89(5):479-84.